TRANSCAN-3 Joint Transnational Call 2024: “Combination therapies against cancer: new opportunities for translational research” – Pre-proposal

Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: Tuesday 2nd, July 2024

External Deadline: Friday 5th, July 2024


CIHR is a partner in the upcoming TRANSCAN-3 Joint Transnational Call (JTC) 2024: “Combination therapies against cancer: New opportunities for translational research”. TRANSCAN-3 JTC 2024 is an international funding opportunity focused on high-impact translational cancer research with anticipated 21 partners from 16 countries.

The main purpose of this call will be design of patient preclinical models for combination therapies. Translational research using tumour samples collected from retrospective and/or prospective cohorts of patients.

 For more details on eligibility criteria and pre-proposal applications, please visit the JTC 2024 webpage. Further instructions for applicants from Canadian institutions will be available on ResearchNet in Spring 2024. Researchers in Canada are strongly encouraged to apply.

Pre-proposals deadline: July 5, 2024
Full proposal deadline: November 29, 2024

Visit the TRANSCAN-3 JTC 2024 webpage.

Funding Sources

CIHR & Joint Transnational Call (JTC) Partners

This opportunity was posted by: RGCS

Last modified: April 26, 2024